ARTICLE | Clinical News
Calypte regulatory update
August 12, 1996 7:00 AM UTC
The FDA licensed CALY's HIV-1 Urine EIA enzyme immunoassay to detect antibodies to HIV-1 in urine. CALY will sell the test directly to 12 U.S.-based laboratories, while Seradyne (Indianapolis, Ind.) h...